Refine your search
Collections
Co-Authors
Journals
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Mary, Angel
- An Overview on Anxiety:Etiology and Therapy
Abstract Views :223 |
PDF Views:83
Authors
Affiliations
1 Krupanidhi College of Pharmacy, 12/1 Chikkabellandur, Carmelaram Post, Bangalore - 35, IN
1 Krupanidhi College of Pharmacy, 12/1 Chikkabellandur, Carmelaram Post, Bangalore - 35, IN
Source
Journal of Pharmaceutical Research, Vol 16, No 1 (2017), Pagination: 32-37Abstract
Purpose: Anxiety disorders have turned out to be the most common mental health conditions prevailing all over the world. The symptoms of anxiety are very common in the community, not only affecting the younger generations but also the elderly. There have been a number of advances in the pharmacotherapy of anxiety disorders in recent decades. Normal anxiety is a kind of emotion that mainly helps to face the threats and problems awaiting an individual. But when this emotion exceeds a certain limit, it causes harm to the same individual. Thus, this paper gives an overall review on what exactly anxiety is, how is it caused and the different treatment methods used so far for anxiety. Apart from this the future aspects has also been covered in this paper.
Approaches: The data were collected from various sources like journal articles, textbooks, internet, related materials in library and databases such as pubmed, google scholar and so on.
Findings: New developments are forthcoming in the field of alternative strategies for managing anxiety and for treatment-resistant cases.
Conclusion: As a word, anxiety may seem very small to read but when it comes to a person's life it can be life threatening. There are varieties of conventional treatment methods available for anxiety and many promising therapies are yet to come.
Keywords
Anxiety Disorders, Epidemiology, Psychological Treatments, Psychotherapy, Antidepressants.Full Text
References
- Spinella M. The Psychopharmacology of Herbal Medicine: Plant Drugs That Alter Mind, Brain and Behaviour. Cambridge, MA: The MIT press. J Psychiatry Neurosci. 2003 Jul; 28(4): 300–301.
- Seligman, Walker EF, Rosenhan DL. Abnormal psychology. 4th Edition. New York: WW Norton & Company. 2001, chapter 7.
- Eisenberg DM, Davis RB, Ettner SL. Trends in alternative medicine use in the United States. The Journal of the American Medical Association. 1998 ;280(18):1569-1575.
- Wittchen HU, Jacobi F. Size and burden of mental disorders in Europe: a critical review and appraisal of 27 studies. Eur. Neuropsycho-pharmacol.2005; 15,357-376.
- Cates M, Wells BG. Anxiety Disorders. Textbook of Therapeutics: Drug and Disease Management.1996: 1073-1093.
- Pies RW. Clinical manual of psychiatric diagnoses and treatment: a biopsychosocial approach. American Psychiatric Press, Washington, DC; Prim Care Companion J Clin Psychiatry. 1999; 1(5): 166.
- Hettema JM, Neale MC, Kendler KS. A review and meta analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry. 2001;158(10):1568-78.
- Torgersen S. Genetic Factors in Anxiety Disorders. Archives of General Psychiatry, 1983;40(10): 1085-1089.
- Tocchetto A, Salum GA. Evidence of association between Val66Met polymorphism at BDNF gene and anxiety disorders in a community sample of children and adolescents. Sep 2011;502(3): 197–200.
- Sandford J J, Argyropoulos SV, Nutt DJ. The psychobiology of anxiolytic drugs Part 1: basic neurobiology. Pharmacology & Therapeutics. 2000;88: 197-212.
- Eysenck MW. Approaches to Abnormality. In MW Eysenck, Psychology: An International Perspective. New York: Psychology Press. 2004: 794-853.
- Sarason IG, Sarason BR. The problem of maladaptive behavior. Abnormal Psychology. 8th Edition. New Delhi: Prentice Hall of India; 2000: 180-207.
- Providing best care for anxiety disorders in general practice. NPS Prescribing Practice Review. NPS MedicineWise; 2009.
- Barbotte E, Guillemin F, Chan N. Prevalence of impairments, disabilities, handicaps and quality of life in the general population: a review of recent literature. The International Journal of Public Health. 2001;79: 1047-1055.
- Majcher D, Pollack MH. Childhood anxiety disorders: Do they grow out of it? Long-term outcomes of childhood disorders. Washington, DC: American Psychiatric Press. 1996: 139-169.
- Offord DR, Boyle MH, Campbell D, Goering P, Lin E, Wong M et al. One-year prevalence of psychiatric disorder in Ontarians 15 to 64 years of age. Can Journal of Psychiatry 1996;41:559-563.
- Eaton WW, Kessler RC, Wittchen HU, Magee WJ. Panic and panic disorder in the United States. Am J Psychiatry. 1994;151:413-420.
- Lepine JP. The epidemiology of anxiety disorders: prevalence and societal costs. Journal of Clinical Psychiatry. 2002;14, 14-18.
- Lisa B, Rivas-Vazquez, Rafael A. Assessment and treatment of social anxiety disorder. Professional Psychology: Research and Practice. 2003: 396-405.
- Whittal ML, Thordarson DS, McLean PD. Treatment of obsessive-compulsive disorder: cognitive behavior therapy vs. exposure and response prevention. 2005;43(12):1559-76.
- James D Herbert, Brandon A. Cognitive behavior therapy for generalized social anxiety disorder in adolescents: A randomized controlled trial. Journal of Anxiety Disorders. 2009: 167–177.
- Knekt P, Lindfors O, Laaksonen MA. Psycho-therapy Study Group. Effectiveness of short-term and long-term psychotherapy on work ability and functional capacity: A randomized clinical trial on depressive and anxiety disorders. Journal of Affective Disorders.2008;107(1-3): 95-106.
- Feldman. American Psychological Association. 2004.
- Snyder BD, Polasek TM, Doogue MP. Drug interactions: principles and practice. AustPrescr 2012;35:85-88.
- Cassano, Giovanni B, Rossi, Nicolò Baldini. Psychopharmacology of anxiety disorders. Dialogues in Clinical Neuroscience. 2002;4(3): 271–285.
- Barlow, David H, Durand, Mark V. Mood Disorders and Suicide. Abnormal Psychology: An Integrative Approach. 2009;239.
- Koen N, Stein DJ. Pharmacotherapy of anxiety disorders: A c r i t i cal rev iew. Dialogues Cl inNeuros c i . 2011;13(4):423–437.
- Ravindran LN, Stein MB. The pharmacologic treatment of anxiety disorders: A review of progress. J Clin Psychiatry. 2010;71(7): 839–854.
- Llorca PM, Spadone C, Sol O. Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3-month double-blind study. J Clin Psychiatry. 2002, November; 63 (11): 1020–1027.
- McDougle CJ. Update on pharmacologic management of OCD: Agents and augmen-tation. J Clin Psychiatry. 1997;58:11–17.
- Ravindran LN, Stein MB. The pharmacologic treatment of anxiety disorders: A review of progress. J Clin Psychiatry.
- Effects of Anemia on Cognitive Function
Abstract Views :207 |
PDF Views:71
Authors
Affiliations
1 Department of Pharmacology, Krupanidhi College of Pharmacy, #12/1, Chikkabellandur, Carmelaram Post, Varthur Hobli, Bangalore - 560035, KA, IN
1 Department of Pharmacology, Krupanidhi College of Pharmacy, #12/1, Chikkabellandur, Carmelaram Post, Varthur Hobli, Bangalore - 560035, KA, IN
Source
Journal of Pharmaceutical Research, Vol 16, No 2 (2017), Pagination: 134-142Abstract
Purpose: To establish the relation between Anemia and cognitive function.
Approach: Published articles from Pubmed and other Internet sources were used to establish the relation between anemia and cognition.
Finding: There are various factors like RBC, hemoglobin and iron content which affects cognition indirectly. Whereas some factors such as defect in gene, directly affects the cognition.
Conclusion: Anemia not only affects the physical health, but also affects the mental health like cognition. RBC, hemoglobin and iron contents affect the cognitive function while due to defect in gene, causes anemia, which also affects cognitive functions. Cognition of infant is also affected by maternal anemia.
Keywords
Anemia, Cognitive Function, RBC, Hemoglobin.Full Text
References
- Janz TG, Johnson RL. Anemia in the emergency department: evaluation and treatment. Emergency medicine practice.2013;15(11):1–15.
- Reid R, Burt A, Harrison D, David J, Levison DA, MacSween RN. Muir's textbook ofpathalogy. 14th edition. United Kingdom: Hodder Education;2008.
- Weiss G, Goodnough LT. Anemia of chronic disease. The NewEngland of Journal Medicine. 2005; 352(10):1011-1022.
- Criswell KA, Sulkanen AP, Hochbaum AF, Bleavins M R . Effects of phenylhydrazine or phlebotomy on peripheral blood, bone marrow and erythropoietin in Wistar rats Journal of Applied Toxicology. 2000;20(1):25-34.
- Charles M, Modibo D, Humphrey M, Alutu M, Erasto M, Seif S, Frank M, Jaffu C. Hematoprotective property of EremomastaxSpeciosa on experimentally induced anemic Wistar rats. Annals of Biological Research.2010;1(2):221-229.
- Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA. A systematic analysis for the Global Burden of Disease Study. Lancet. 2012;380(9859):2095-128.
- SpivakJL.Polycythemia Vera: myths, mechanisms, and management. Blood 2002;100(13):4272-90.
- EngelfrietCP, Overbeeke MA, von dem Borne AE, Perrotta PL, Snyder EL. Autoimmune hemolytic anemia,Non-infectious complications of transfusion therapy. Blood Review 2001;15(2): 69-83.
- Symptoms and causes - Anemia - Mayo Clinic [Internet]. Mayoclinic.org. 2017 [cited 10 November 2016]. Available from: http://www.mayoclinic.org/diseases- conditions/anemia/symptomscauses/ dxc-20183157.
- Cognition - definition of cognition in English | Oxford Dictionaries [Internet]. Oxford Dictionaries | English. 2017 [cited 24 October 2016]. Available from: https://en.oxforddictionaries.com/definition/cognition.
- Michelon D. What are Cognitive Abilities and Skills, and How to Boost Them? [Internet]. SharpBrains. 2017 [cited 5 January 2017]. Available from: http://sharpbrains.com/blog/2006/12/18/what-are-cognitive-abilities.
- Dutta J. What are the Factors Affecting Cognitive Development of Children? [Internet]. Preservearticles.com. 2017 [cited 16 January 2017]. Available from: http://www.preservearticles.com/2011100714884/what-are-thefactorsaffecting-cognitive-development-of-children.html.
- McLeod S. Jean Piaget | Cognitive Theory | Simply Psychology [Internet]. Simplypsychology.org. 2017 [cited 10 January 2017]. Available from: http://www.simplypsychology.org/piaget.html.
- Hasher L, Zacks RT. working memory comprehension and aging.International journal of behavioral development. 1998;22(4):193-225.
- Janowsky JS. Testosterone and cognition. Trends in cognitive sciences. Journal of clinical and diagnostic research. 2006;10(2):77-82.
- Sherwin BB. Estrogen and cognitive function in women.endocrine review.2003; 24(2):133-151.
- Zaidi ZF. Gender difference in human brain. The open anatomy journal.2010; 24(2):37-55.1
- Anett N, Jianghong Li, Wendy H .The role of nutrition in children's neurocognitive development, from pregnancy through childhood. Frontier in HYPER LINK "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607807/"HumHYPERLINK "https://www.ncbi.nlm.nih.gov/ pmc/articles/ PMC3607807/"anHYPERLINK "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607807/"Neuro science. 2013; 7: 97.
- Pollitt E. Iron deficiency and cognitive function.Annual Review of Nutrition. 1993;13: 521–537.
- Polich J. P300 in the evaluation of aging and dementia. Electroencephalography and clinical neurophysiology Supplement.Journal of geriatric psychiatry and neurology. 1991;42:304–323.
- Harris WS, Thomas RM. Biological variability of blood omega-3 biomarkers. Clinical Biochemistry.Elsevier. 2010;43(3):338–340.
- Arab L. Biomarkers of fat and fatty acid intake. The journal of nutrition.2003;133(3):925S–932S.
- Brenna JT. Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man. Current opinionin clinical nutrition and metabolic Care. 2002;5(2):127–132.
- Heude B, Ducimetiere P, Berr C.Cognitive decline and fatty acid composition of erythrocyte membranes: the EVA Study. The American Journal of Clinical Nutrition. 2003;77(4):803–808.
- Muskiet FA, Fokkema MR, Schaafsma A, Boersma ER, Crawford MA. Lessons from DHA status regulation, our ancient diet, epidemiology and randomized controlled trials. The journal of Nutrition. 2004;134(1):183–186.
- Yurko-Mauro K, McCarthy D, Rom D. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimer's and Dementia. The journal of the Alzheimer's association. 2010;6(6):456–464.
- Denny SD, Kuchibhatla MN, Cohen HJ. Impact of anemia on mortality, cognition, and function in community-dwelling elderly.The American journal of medicine. 2006;119(4):327–334.
- Chaves PH, Carlson MC, Ferrucci L, Guralnik JM, Serba R, Fried LP. Association between mild anemia and executive function impairment in communitydwelling older women: the Women's Health and Aging Study II. Journal of the American Geriatric Society.2006;54(9):1429–1435.
- Michael WP. Bone Marrow Failure Disease and the Brain. Centre for Brain Health Neurologic Institute. http://w w w.aamds.org/sites default/files/AAMDS%20and% 20brain_MWP_2015_rev.pdf 2015
- Ballin A, Berar M, Rubinstein U. Iron state in the female adolescent. The American Journal of Diseases of Children. 1992;146(7):803–805.
- Groner N A, Holtzman N A, Charney E, Mellits D. A randomized trial of oral iron on tests of short-term memory and attention span in young pregnant women. Journal of Adolescent Health Care.1986;7(1):44–48.
- Walter T. Impact of iron deficiency on cognition in infancy and childhood. European Journal of Clinical Nutrition. 1993;47(5):307-316.
- Grantham M S, Ani C. A review of studies on the effect of iron deficiency on cognitive development in children. Journal of Nutrition.2001;131(2S2):649–666.
- Deungria M. Perinatal iron deficiency decreases cytochrome c oxidase (CytOx) activity in selected regions of neonatal rat brain. Pediatric Research. 2000;48(2):169–176.
- Lozoff B, Georgieff M K. Iron deficiency and brain development. Seminar in Pediatric Neurology. 2006;13(3):158–165.
- Georgieff M K. Nutrition and the developing brain: nutrient priorities and measurement. The American journal of clinical Nutrition. 2007;85(2):614S–620S.
- Rioux FM., Bélanger PJ, Leblanc C P, Vigneau F. Relationship between maternal DHA and iron status and infants' cognitive performance. Canadian Journal of Dietetic Practice and Research.2016;16 : 72-76.
- Jorgenson LA, Wobken JD, Georgieff MK. Perinatal iron deficiency alters apical dendritic growth in hippocampal CA1 pyramidal neurons. Dev. Neurosci. 2003;25(6): 412–420.
- Nagalakshmi P, Santhosh H, Shobha C. A study of Correlation Between Hemoglobin Level and Cognitive Function in Children from Rural Area Staying in Residential School. Indian JounalPhysiology Pharmacology 2015;59(3):308–312.
- Walden H, Deans A J. "The Fanconi Anemia DNA Repair Pathway: Structural and Functional Insights into a Complex Disorder". AnnualHYPERLINK "https://en.wikipedia.org/w/index.php?title=Ann._Rev._Biophysics&acti on=edit&redlink=1" RevHYPERLINK "https://en.wikipedia.org/w/i ndex.php?title=Ann._Rev._Biophysics&action=edit&redlink=1"iew HYPER LINK "https://en.wikipedia.org/w/index.php?title=Ann._Rev._Biophysics&action=edit&redlink=1"of HYPERLINK "https://en.wikipedia.org/w/index.php?title=Ann._Rev._Biophysics&acti on=edit&redlink=1"Biophysics. 2014;43(1):257–278.
- Sumpter R, Sirasanagandla S, Fernandez A, Dong X, Franco L, Zhongju Z et al. Fanconi Anemia Proteins Function in Mitophagy and Immunity. 2016;165(4):867-881.
- David C Y, Dean RT, Michael FM, David J H, Basil TD, Alon G et al.Hemolytic anemia and severe rhabdomyolysis caused by compound heterozygous mutations of the gene for erythrocyte/muscle isozyme of aldolase, ALDOA(Arg303X/Cys338Tyr)Blood. 2004;103(6):2401-2403.
- Steen RG, Xiong X, Mulhern RK, Langston JW, Wang WC. Subtle brain abnormalities in children with sickle cell disease: relationship to blood hematocrit. Annals of Neurology. 1999;45(3):279–286.
- Brown RT, Buchannan I, Doepke K. Cognitive and academic functioning in children with sickle cell disease. Journal of Clinical Child Psychology. 1993;22:207–218.
- Galanello R, Origa R. Beta-thalassemia. OrphanetJournal of Rare Diseases. 2010;5:11.
- Cakaloz B, Cakaloz I, Polat A, Inan M, Oguzhanoglu NK. Psychopathology in thalassemia major. Pediatric International: official journal of the Japan pediatric society. 2009; 51(6):825-828.
- Hajibeigi B, Azarkeyvan A, Alavian SM, Lankarani MM, Assari S. Anxiety and depression affects life and sleep quality in adults with beta-thalassemia. Indian JHematolBlood Transfus .2009;25(2):59-65.
- Pakbaz Z, Treadwell M, Yamashita R, Quirolo K, Foote D, Quill L. Quality of life in patients with thalassemia intermedia compared to thalassemia major. Annals of New York Academy of Science 2005;1054:457-461.
- Marsh JT, Brown WS, Wolcott D.rHuEPO treatment improves brain and cognitive function of anemic dialysis patients. Kidney International. Official Journal of The International Society Of Nephrology. 1991;39(1):155–163.
- Cold F, Health E, Disease H, Management P, Conditions S, Problems S et al. Folic Acid for Good Health [Internet]. WebMD. 2017 [cited 2 November 2016]. Available from: http://www.webmd.com/diet/supplement-guide-folicacid# 1.
- Martha D, Angela W, Christian W, Durig J, Martina BP, Dragano N, Moebus S, Jöckel KH, Erbel R, Eisele L. Anemia and Mild Cognitive Impairment in the German General Population. Journal of Alzheimer's disease. 2016;49(4):1031-42.
- Lozoff B, Klein NK, Nelson EC, McClish DK, Manuel M, Chacon ME. Behavior of infants with iron-deficiency anemia. Child Development. 1998; 69(1):24–36.
- http://www.pinsdaddy.com/cognitive-part-of- thebrain_7qI Wy W0G37iinqAWYbiTGA9lHpcEA1QLgBc7wWCl8h4/
- Coel CL, Lubach GR, Schneider ML. Neuromotor and socio-emotiional behaviour in the young monkey are presaged by prenatal conditions. In: Lewis M. Ramsey D, editors, Stress and Soothing. Hillsdale, NJ: Lawrence Erlbaum; 1999. 19-38.
- Golub MS, Hogrefe CE, Widaman KF, Capitanio JP, Iron deficiency anemia and affective response in rhesus monkey infants. Dev Psychobiol.2009;51(1):47-59.